Sign up
Pharma Capital

Clinigen's Shaun Chilton 'couldn't be happier' with full year performance

Shaun Chilton, chief executive of Clinigen Group PLC (LON:CLIN) tells Proactive that organic growth, a currency boost and full contribution from recent acquisition Link Healthcare helped them to increase gross profits by 22% in the year to June.


View full CLIN profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.